Nuestro artículo en Medicine‼️
📌Protocolo diagnóstico ante la sospecha de feocromocitoma
✍️Ante la sospecha de un feocromocitoma, el primer paso es demostrar que existe una producción excesiva de catecolaminas
https://t.co/lFBhPwCtbC
Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis | Diabetes Technology & Therapeutics https://t.co/FIwB75Q2uY
Download our new and improved Abridged Standards of Care (SOC), the go-to guide for primary care professionals, available for FREE. For the first time ever, we’ve condensed the SOC into easy to ready graphics. Don’t delay, download today! https://t.co/Lh8aXod9FR
A Swedish-based cohort study on familial aggregation and heritability of childhood-onset and adult-onset #T1D.
Findings suggest a larger contribution of environmental factors to the development of T1D in adults than in children.
Read it here: https://t.co/lJsjIbGaW0
If you haven't already, read the @Soc_Endo guideline article on the diagnosis and management of post-bariatric hypoglycaemia. By @hazlehurst_j et al.
➡️➡️https://t.co/9ZRSGY2XT5
Mean Glucose and Gestational Weight Gain as Predictors of Large-for-Gestational-Age Infants in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitoring | Diabetes Technology & Therapeutics https://t.co/wy28xwxHas
@estebanjodar Muy importante: el inicio de iSGLT2 en FGe < 20 sigue protegiendo la progresión de la enfermedad renal y enlentece la llegada a diálisis!!
👉👉👉HIPOGLUCEMIAS, ¿cómo actuar?
🔗vídeo en https://t.co/zHgbaLZovq
✏️En GUÍA DE SUPERVIVENCIA PARA LAS PERSONAS CON DIABETES Y SUS CUIDADORES multimedia @SAEDYN_
práctico, didáctico, sencillo
🔗Guía de supervivencia completa en https://t.co/CnHXFnhsCu
#Glucagon, from past to present: a century of intensive research and controversies https://t.co/FfFclfQszb #diabetes#obesity#FREE to read with registration (also FREE)
Diabetic kidney disease has high associated cardiovascular death. SGLT2 inhibitors or finerenone, when either is combined alone with RAS blockade, curtails DKD. Management of DKD requires a “pillared approach.” @ADA_Pubs
Read Here➡️https://t.co/MRFRYox7Gj
2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Principal new points 👇👇 @secardiologia@escardio#ESCCongress
⚠️Management HFpEF
⚠️Management HFmrEF
📥 https://t.co/ykRS4jhc8c
Incretins: turning the venom into the antidote. Read the Editorial on our 2023 Incretins in Metabolic Disease Special Issue! #Incretin#GLP1RA#T2D#T1D#MetabolicDisease https://t.co/7L7DI2bayh
Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study @DiabetesCareADA
https://t.co/6DFKhPajLb
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement https://t.co/hrNXB9ycr0 #CGM#diabetes#FREE to read with registration (also FREE)